IDSA News - February 2013  (Plain Text Version)

Return to Graphical Version


In this issue:
Patient Care and Science
•  CDC Urges Additional Steps for Preventing CRE Spread
•  HAI Report: Progress on Some Infections, Still Work to Be Done
•  New Influenza Vaccines Will Be Added to ACIP Guidance for Next Season
Clinical Practice Management
•  IDSA Practice Management Listserve: Are You Connected?
Global ID
•  Health and Justice in a Haitian Prison: Making Progress
•  IOM Highlights PEPFAR’s Successes, Makes Recommendations
•  Substandard TB Drugs Widely Used, Study Suggests
Policy and Advocacy
•  Momentum Builds for New Antibiotic Approval Pathway
•  Bill Would Allow Research on HIV-Infected Organ Donation to HIV Patients
•  U.S. Government Updates Policies on H5N1, Dual Use Research
Your Colleagues
•  Check Out “My IDSA” for Latest Member News
Education & Resources
•  Prepping for the ID Board Exam? IDSA’s Practice Exam Can Help
•  Online Now: Infections in Older Adults Course
Top Stories
•  From the President: Telling the ID Story
•  Urge Lawmakers to Stop Federal Funding and Medicare Cuts
•  New Guidelines: Surgical Prophylaxis, Sepsis and Septic Shock
•  IDSA Journal Club


CDC Urges Additional Steps for Preventing CRE Spread

The Centers for Disease Control and Prevention (CDC) earlier this month recommended additional steps for clinicians to prevent the spread of carbapenem-resistant Enterobacteriaceae (CRE), in response to increased reports of the difficult-to-treat multidrug-resistant organisms. Of the 37 unusual forms of CRE that have been reported in the U.S., the last 15 have been reported since July 2012.

The additional recommendations were outlined in a Feb. 14 health advisory for health care providers. CDC also recommends that facilities continue to follow existing CDC guidance for preventing the spread of CRE in health care settings.

IDSA members can sign up online to receive similar alerts and updates from CDC and the Food and Drug Administration (FDA). (To subscribe to these services, check the appropriate boxes to receive CDC’s Health Alert Network (HAN) messages and/or alerts from FDA, and provide your email address and name where indicated.)